美国 · 财经报刊 · Investor's Business Daily
AbbVie's Earnings Double As Immunology Powerhouse Skyrizi Beats Again
AbbVie stock slipped slightly Friday, but the drug giant easily beat third-quarter forecasts with the help of its biggest drug, Skyrizi. The post AbbVie's Earnings Double As…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
